FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next
- Posted on December 19, 2024
- By AOL
- 2 Views
FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next
The FDA decided the shortage for Eli Lilly's GLP-1 tirzepatide has finally come to an end.
